To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?
LetterAçık Erişim
Anahtar Kelimeler
Fatty LiverGhrelinHumansIntercellular Signaling Peptides and ProteinsProtease InhibitorsSerpinsamino acidapelinapelin 36aprotininbenzylsulfonyl fluoridecaspasegamma glutamyltransferasekallikrein inhibitorobestatinproteinase inhibitorunclassified drugvaspinapoptosisbiochemistryblood analysisdisease coursegamma glutamyl transferase blood levelgastrointestinal tracthormone blood levelhumanletterliver cirrhosisnonalcoholic fatty liverpriority journal
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15642Resmi atıflarda kullanılan kalıcı adresTam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Aydin, Suleyman | |
| dc.contributor.author | Sahin, Ibrahim | |
| dc.contributor.author | Demirel, Ulvi | |
| dc.contributor.author | Aksoy, Aziz | |
| dc.date.accessioned | 2026-10-18T20:30:29.167157990Z | |
| dc.date.available | 2026-10-18T20:30:29.167157990Z | |
| dc.date.issued | 2011 | |
| dc.identifier.doi | 10.1016/j.metabol.2011.01.015 | |
| dc.identifier.issn | 1532-8600 | |
| dc.identifier.issue | 7 | |
| dc.identifier.pmid | 21397283 | |
| dc.identifier.scopus | 2-s2.0-79959357939 | |
| dc.identifier.startpage | E1 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/15642 | |
| dc.identifier.volume | 60 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Metabolism: Clinical and Experimental | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Fatty Liver | |
| dc.subject | Ghrelin | |
| dc.subject | Humans | |
| dc.subject | Intercellular Signaling Peptides and Proteins | |
| dc.subject | Protease Inhibitors | |
| dc.subject | Serpins | |
| dc.subject | amino acid | |
| dc.subject | apelin | |
| dc.subject | apelin 36 | |
| dc.subject | aprotinin | |
| dc.subject | benzylsulfonyl fluoride | |
| dc.subject | caspase | |
| dc.subject | gamma glutamyltransferase | |
| dc.subject | kallikrein inhibitor | |
| dc.subject | obestatin | |
| dc.subject | proteinase inhibitor | |
| dc.subject | unclassified drug | |
| dc.subject | vaspin | |
| dc.subject | apoptosis | |
| dc.subject | biochemistry | |
| dc.subject | blood analysis | |
| dc.subject | disease course | |
| dc.subject | gamma glutamyl transferase blood level | |
| dc.subject | gastrointestinal tract | |
| dc.subject | hormone blood level | |
| dc.subject | human | |
| dc.subject | letter | |
| dc.subject | liver cirrhosis | |
| dc.subject | nonalcoholic fatty liver | |
| dc.subject | priority journal | |
| dc.title | To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease? | |
| dc.type | Letter | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 2 | |
| rdl.source.index | SCOPUS |
